| name | es-cushing-serum-sodium-monitoring-post-tss |
| description | This skill recommends measuring serum sodium several times during the first 5–14 days after transsphenoidal surgery to detect and manage electrolyte disturbances such as postoperative hyponatremia and diabetes insipidus. Use when managing a post-TSS Cushing’s syndrome patient in the early recovery phase; triggers include postoperative day 5–10 hyponatremia, polyuria, fluid intake‑output imbalance, or suspected diabetes insipidus. |
Serum Sodium Monitoring Several Times During First 5-14 Days Post-TSS
STEP 1 — Gather Information
Record postoperative day, serum sodium, fluid intake and output (urine volume, IV fluids), weight change, vital signs, and neuro symptoms (confusion, headache, seizures).
STEP 2 — Rule In / Rule Out
Determine if serum sodium is low (<135 mmol/L) suggesting SIADH, high (>145 mmol/L) suggesting diabetes insipidus, or normal with high urine output (>200 mL/hr) suggestive of DI.
STEP 3 — Classify or Stratify
Classify the disturbance as SIADH, diabetes insipidus, or electrolyte stable based on sodium trend, urine output, and clinical context.
STEP 4 — Decide
Initiate fluid restriction (800–1000 mL/day) and frequent sodium checks for SIADH; start desmopressin (1–2 mcg IV/PO q6–8h) and monitor urine output and sodium for DI; involve endocrinology for both.
Clinical Guardrails / Mimics / Pitfalls
Avoid rapid sodium correction (>6–8 mmol/L in 24 h) to prevent osmotic demyelination; do not give free water in hyponatremia; do not administer desmopressin without confirmed DI; watch for over‑correction when switching from SIADH to DI; ensure emergency staff know to contact endocrinology for hyponatremia post‑TSS.
Concrete Clinical Example
A 48‑year‑man postoperative day 9 after TSS for Cushing’s disease has serum Na 126 mmol/L, urine output 25 mL/hr, 1.5 kg weight gain, and mild lethargy. Fluid restricted to 800 mL/day, sodium checked every 4 h, endocrinology consulted; sodium rises to 132 mmol/L by day 11.
Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2015-1818
